ARCHIVES

NCI Officials Open To Fine-Tuning Group Budgets As Advocates Chip Away At NCTN’s Façade

This article is from The Cancer Letter archive.

Vol. 40 No. 18 | May 2, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002

Season’s Greetings from the Cancer Letter

December 17, 1999

UC Davis Is U.S. Site For Trial Of Exemestane For Breast Ca.

September 24, 2004

GAO Report: Taxol CRADA “Successful,” But Not Great Financial Deal.

June 27, 2003

Surgical Oncologists Honor HHS Secretary

March 22, 2002

PET/CT Imaging During Treatment Shows Whether Chemo Is Working, Study Finds

April 24, 2009